Nicolaou N, Siddique N, Custovic A. Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization, Allergy. Eur J Allergy Clin Immunol. 2005;60:1357–60. https://doi.org/10.1111/j.1398-9995.2005.00961.x.
Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355:2226–35.
Article PubMed CAS Google Scholar
Nathan RA, Meltzer EO, Seiner JC, Storms W. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99:S808–14. https://doi.org/10.1016/S0091-6749(97)80040-1.
Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin SL. The burden of adult asthma in the United States: evidence from the medical expenditure panel survey. J Allergy Clin Immunol. 2011;127:363–e3693. https://doi.org/10.1016/J.JACI.2010.10.042.
Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy: Eur J Allergy Clin Immunol. 2004;59:469–78. https://doi.org/10.1111/j.1398-9995.2004.00526.x.
Larsen JN, Broge L, Jacobi H. Allergy immunotherapy: the future of allergy treatment. Drug Discov Today. 2016;21:26–37. https://doi.org/10.1016/j.drudis.2015.07.010.
Article PubMed CAS Google Scholar
Ranjbar M, Whetstone CE, Omer H, Power L, Cusack RP, Gauvreau GM. The genetic factors of the airway epithelium associated with the pathology of asthma. Genes (Basel). 2022;13. https://doi.org/10.3390/genes13101870.
Falcon RMG, Caoili SEC. Immunologic, genetic, and ecological interplay of factors involved in allergic diseases. Front Allergy. 2023;4:1215616. https://doi.org/10.3389/falgy.2023.1215616.
Article PubMed PubMed Central Google Scholar
Sengler C, Lau S, Wahn U, Nickel R. Interactions between genes and environmental factors in asthma and atopy: new developments. Respir Res. 2001;3. https://doi.org/10.1186/rr179.
Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454:445–54. https://doi.org/10.1038/nature07204.
Article PubMed PubMed Central CAS Google Scholar
Larché M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006;6:761–71. https://doi.org/10.1038/nri1934.
Article PubMed CAS Google Scholar
Kündig TM, Bachmann MF. Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG? Hum Vaccin. 2010;6:673–5. https://doi.org/10.4161/hv.6.8.12007.
Article PubMed CAS Google Scholar
Frew AJ. Allergen immunotherapy. J Allergy Clin Immunol. 2010;125:S306–13. https://doi.org/10.1016/j.jaci.2009.10.064.
Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol. 2004;113:395–400. https://doi.org/10.1016/j.jaci.2003.11.025.
Article PubMed CAS Google Scholar
Rivera J, Fierro NA, Olivera A, Suzuki R. New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol. 2008;98:85–120. https://doi.org/10.1016/S0065-2776(08)00403-3.
Article PubMed PubMed Central CAS Google Scholar
Tauber PA, Pickl WF. Pharmacological targeting of allergen-specific T lymphocytes. Immunol Lett. 2017;189:27–39. https://doi.org/10.1016/j.imlet.2017.03.010.
Article PubMed PubMed Central CAS Google Scholar
Bousquet J, Lockey R, Malling HJ, Alvarez-Cuesta E, Canonica GW, Chapman MD, Creticos PJ, Dayer JM, Durham SR, Demoly P, Goldstein RJ, Ishikawa T, Ito K, Kraft D, Lambert PH, Løwenstein H, Müller U, Norman PS, Reisman RE, Valenta R, Valovirta E, Yssel H. Allergen immunotherapy: therapeutic vaccines for allergic diseases - a WHO position paper. J Allergy Clin Immunol. 1998;102:558–62. https://doi.org/10.1016/s0091-6749(98)70271-4.
Article PubMed CAS Google Scholar
Rolland JM, Gardner LM, O’Hehir RE. Allergen-related approaches to immunotherapy. Pharmacol Ther. 2009;121:273–84. https://doi.org/10.1016/j.pharmthera.2008.11.007.
Article PubMed CAS Google Scholar
Rolland JM, Douglass J, O’Hehir RE. Allergen immunotherapy: current and new therapeutic strategies. Expert Opin Investig Drugs. 2000;9:515–27. https://doi.org/10.1517/13543784.9.3.515.
Article PubMed CAS Google Scholar
Gunawardana NC, Durham SR. New approaches to allergen immunotherapy, annals of allergy. Asthma Immunol. 2018;121:293–305. https://doi.org/10.1016/j.anai.2018.07.014.
Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2007;119:780–9. https://doi.org/10.1016/j.jaci.2007.01.022.
Article PubMed CAS Google Scholar
Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: the world allergy organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol. 2010;125:569–e5747. https://doi.org/10.1016/j.jaci.2009.10.060.
Winther L, Arnved J, Malling H-J, Nolte H, Mosbech H. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study. Clin Exp Allergy. 2006;36:254–60. https://doi.org/10.1111/j.1365-2222.2006.02340.x.
Article PubMed CAS Google Scholar
Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy: Eur J Allergy Clin Immunol. 2006;61:1236–7. https://doi.org/10.1111/j.1398-9995.2006.01155.x.
Kelly CP, Murray JA, Leffler DA, Getts DR, Bledsoe AC, Smithson G, First MR, Morris A, Boyne M, Elhofy A, Wu T-T, Podojil JR, Miller SD. TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled study. Gastroenterology. 2021;161:66–e808. https://doi.org/10.1053/j.gastro.2021.03.014.
Article PubMed CAS Google Scholar
Freitag TL, Podojil JR, Pearson RM, Fokta FJ, Sahl C, Messing M, Andersson LC, Leskinen K, Saavalainen P, Hoover LI, Huang K, Phippard D, Maleki S, King NJCC, Shea LD, Miller SD, Meri SK, Getts DR. Gliadin nanoparticles induce immune tolerance to gliadin in mouse models of celiac disease. Gastroenterology. 2020;158:1667–e168112. https://doi.org/10.1053/j.gastro.2020.01.045.
Article PubMed CAS Google Scholar
Scotland BL, Shaw JR, Dharmaraj S, Caprio N, Cottingham AL, Joy Martín J, Lasola JJ, Sung RM, Pearson. Cell and biomaterial delivery strategies to induce immune tolerance. Adv Drug Deliv Rev. 2023;203:115141. https://doi.org/10.1016/j.addr.2023.115141.
Yeste A, Nadeau M, Burns EJ, Weiner HL, Quintana FJ. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci. 2012;109:11270–11275. https://doi.org/10.1073/pnas.1120611109.
LaMothe RA, Kolte PN, Vo T, Ferrari JD, Gelsinger TC, Wong J, Chan VT, Ahmed S, Srinivasan A, Deitemeyer P, Maldonado RA, Kishimoto TK. Tolerogenic nanoparticles induce antigen-specific regulatory T cells and provide therapeutic efficacy and transferrable tolerance against experimental autoimmune encephalomyelitis. Front Immunol. 2018;9. https://doi.org/10.3389/fimmu.2018.00281. https://www.frontiersin.org/articles/.
Pearson RM, Podojil JR, Shea LD, King NJC, Miller SD, Getts DR. Overcoming challenges in treating autoimmuntity: development of tolerogenic immune-modifying nanoparticles. Nanomedicine. 2019;18:282–91. https://doi.org/10.1016/j.nano.2018.10.001.
Article PubMed CAS Google Scholar
Kheradmand T, Wang S, Gibly RF, Zhang X, Holland S, Tasch J, Graham JG, Kaufman DB, Miller SD, Shea LD, Luo X, Krishna SS, Farhana SA, T.P A, Hussain SM, Viswanad V, Nasr MH, Sahu RK, Khan J. Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials. 2011;32:4517–24. https://doi.org/10.1016/j.biomaterials.2011.03.009.
Article PubMed PubMed Central CAS Google Scholar
Krishna SS, Farhana SA, T.P A, Hussain SM, Viswanad V, Nasr MH, Sahu RK, Khan J. Modulation of immune response by nanoparticle-based immunotherapy against food allergens. Front Immunol. 2023;14:1–17. https://doi.org/10.3389/fimmu.2023.1229667.
Comments (0)